#ScienceMadeSimple
E3: Are all stem cells the same?
My brain went straight to Pokémon, same category, wildly different abilities. Turns out stem cells really do have different “résumés.” 🧬 Keep digging into the research at AdiaMed.com.

#DarkstarDecodes #AdiaMed #StemCells #StemCellResearch #ScienceMadeSimple
September 24, 2026 at 5:39 PM
Your eyes clean themselves over 20,000 times a day without you noticing!

#HiddenBodyFacts #EyeHealth #BodySecrets #CoolBodyFacts #ScienceMadeSimple #DidYouKnowThis #Good2KnowSo
August 7, 2025 at 12:02 PM
Morning Bluesky! Loving this simple definition of an Avalanche Photodiode from one of our semiconductor researchers last week #ScienceMadeSimple
December 3, 2024 at 8:41 AM
Something exciting is on the way. This festive season, we’ll be unwrapping the basics of fusion energy and exploring the STEP programme. Stay tuned!

#FusionUnwrapped #ScienceMadeSimple #EnergyExplained
December 10, 2024 at 4:36 PM
To understand the potential of wetlands to mitigate climate change, Dr. Murray and her team regularly measure greenhouse gas emissions in wetlands with a #ScienceMadeSimple, but clever device called a floating chamber. 3/
June 5, 2025 at 5:16 PM
Results from the NeoADAURA trial, which explores using targeted therapy before surgery in early stage #LungCancer, were recently presented at #ASCO25. LCRF's Chief Scientific Officer Dr. Antoinette Wozniak, explains what we know so far. LCRF.org/sms250728
#ScienceMadeSimple
July 28, 2025 at 6:50 PM
The FDA approved larotrectinib for adult and pediatric patients with NTRK gene fusion-positive cancer tumors. What does this mean? LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains: LCRF.org/sms250424 #LungCancer #ScienceMadeSimple
Science Made Simple: drug approval for NTRK - Lung Cancer Research Foundation
The good news The Food and Drug Administration (FDA) approved larotrectinib (Vitrakvi) for adult and pediatric patients with NTRK gene fusion-positive solid tumors. Why it’s important Neurotrophic…
LCRF.org
April 24, 2025 at 7:00 PM
CRISPR-based technologies are famous for their ability to edit the DNA. But did you know that we can also use CRISPR to edit the RNA? Wanna learn how RNA editing works? Check out our explainer! #CRISPR #RNAediting #geneediting #sciencecommunication #sciencemadesimple #genomeediting
WeDoCRISPR on LinkedIn: RNA Editing
CRISPR-based technologies are famous for their ability to edit the DNA. But did you know that we can also use CRISPR to edit the RNA? RNA is like a photocopy…
www.linkedin.com
February 18, 2025 at 9:36 AM
#ICYMI #ScienceMadeSimple #ASCO2026 - The plenary session of ASCO's 2026 annual meeting featured three presentations which could impact #LungCancer treatment. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means. LCRF.org/sms26ASCO
Work presented at ASCO meeting could impact lung cancer treatment - Lung Cancer Research Foundation
The good newsThree of the top five presentations at the plenary session of the annual ASCO meeting could potentially impact lung cancer treatment. These presentations typically spotlight major…
LCRF.org
July 2, 2026 at 7:26 PM
#ScienceMadeSimple #EnergyExplained

*We’re breaking down fusion, fact by fact. Don’t miss the next one, give us a follow.*
December 19, 2024 at 10:08 AM
What is fusion energy?

Fusion is the process whereby two atomic nuclei combine to form a heavier nucleus, releasing vast amounts of energy. It’s the same process that powers the sun and offers a potential source of clean, limitless energy on Earth.

#FusionUnwrapped #ScienceMadeSimple
December 11, 2024 at 1:34 PM
#ICYMI #ScienceMadeSimple - The FDA granted accelerated approval for zongertinib as a first-line treatment for HER2+ non-small cell #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, unpacks what this means. LCRF.org/sms260424
Zongertinib approved as first-line HER2+ lung cancer treatment - Lung Cancer Research Foundation
The good news The U.S. Food and Drug Administration (FDA) has granted accelerated approval to zongertinib for the treatment of adult patients with metastatic non-squamous non-small cell lung cancer…
www.lungcancerresearchfoundation.org
May 1, 2026 at 3:15 PM
...for new growth and regeneration in the region.

#FusionUnwrapped #ScienceMadeSimple #EnergyExplained

*Hit follow so you don’t miss the next fact!* 3/3
December 31, 2024 at 9:41 AM
#ScienceMadeSimple #EnergyExplained

*This fact is part of a series exploring the basics of fusion. Hit follow so you don’t miss the next release!*
December 21, 2024 at 11:39 AM
...from fusion and further demonstrate the path to commercialisation of fusion energy.

#FusionUnwrapped #ScienceMadeSimple #EnergyExplained

*Curious about fusion or STEP? Follow us for more facts.* 2/2
January 4, 2025 at 2:00 PM
2025 was a tremendous year for #LungCancer research. LCRF's Chief Scientific Officer, Antoinette Wozniak, MD, outlines the developments and what they mean going forward. #ScienceMadeSimple LCRF.org/hizrw
Lung cancer in 2025 - Lung Cancer Research Foundation
The good news I have been a Medical Oncologist for over 40 years, and I have had the privilege of witnessing an explosion of advancements in the treatment of lung […]
www.lungcancerresearchfoundation.org
January 29, 2026 at 7:53 PM
1/12 Let's talk about two recent breastfeeding studies that might be causing unnecessary alarm for parents. I'm breaking it down so you don't have to panic! #ParentingFacts #BabyFeeding #ScienceMadeSimple 🧵
April 9, 2025 at 6:08 PM
We will hold this heated gas, called plasma, using strong magnets in a machine called a ‘tokamak’.

#FusionUnwrapped #ScienceMadeSimple #EnergyExplained

*Hit follow so you don’t miss the next fact!*
December 23, 2024 at 10:48 AM
📄 New Lay Summary: Finding Better Ways to Predict and Prevent Psoriatic Arthritis 🔬

📊 View the graphical abstract
🔗 Visit our website to read the full lay summary: hippocrates-imi.eu/publications...

#LaySummary #ScienceMadeSimple #Psoriasis #PsoriaticArthritis #biomarkers #omics
June 29, 2026 at 7:42 AM
...the carbon used to manufacture the components and buildings, and to start up the plant.

#FusionUnwrapped #ScienceMadeSimple #EnergyExplained

*Keep learning about fusion! Follow us for the next fact in this series.*
December 17, 2024 at 11:42 AM
📄 New Lay Summary: Pain Patterns May Reveal Early Joint Inflammation in People with Psoriasis

📊 View the graphical abstract
🔗 Visit our website to read the full lay summary: hippocrates-imi.eu/publications...

#LaySummary #ScienceMadeSimple #Psoriasis #PsoriaticArthritis #AIinHealthcare
May 7, 2026 at 1:11 PM
Fun Fact time!🎉

Teachers have used illustrated comics to simplify chemistry concepts like the periodic table, making complex formulas feel less intimidating.⚛️🤩

ScAIentist builds on that approach—helping make complex topics more fun!✨

#VisualEducation #ScienceMadeSimple #ScAIentist #fff #funfact
June 13, 2025 at 12:43 PM
...with the global energy market expected to be worth trillions of pounds per year. Commercial fusion will have a big role to play.

#FusionUnwrapped #ScienceMadeSimple #EnergyExplained

*Hit follow so you don’t miss the next fact!*
December 13, 2024 at 9:58 AM
#ScienceMadeSimple: FDA has granted accelerated approval to sevabertinib for treating HER2+ (ERBB2) #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means for patients. LCRF.org/sms25121
Sevabertinib for HER2+ lung cancer - Lung Cancer Research Foundation
The good news The U.S. Food and Drug Administration (FDA) has granted accelerated approval to sevabertinib for the treatment of adult patients with unresectable or metastatic non-squamous non-small…
LCRF.org
December 2, 2025 at 5:30 PM